Simulab Corporation

Simulab Corporation, doing business as Simulab Corp, manufactures high-fidelity medical simulation training equipment and replaceable anatomical components for federal defense and healthcare agencies, operating as a prime contractor on full-and-open federal awards with no set-aside designations. The company is a self-certified small disadvantaged business headquartered in Tukwila, Washington, with place of performance in Burien and Seattle, Washington, structured as a for-profit Subchapter S corporation competing across 1,360 prime federal contract awards spanning medical device supply, surgical training systems, and procedural simulators.

Simulab's customer concentration is extreme: the Defense Logistics Agency Troop Support Medical accounts for 1,073 awards (79% of the prime footprint) worth $54.6 million combined potential value, anchoring the federal business almost entirely to defense medical readiness. The Department of the Army, Department of the Navy, Uniformed Services University of the Health Sciences, and the Department of the Air Force comprise the remaining 12% of awards by count but only 6% by value, leaving Simulab deeply exposed to DLA Troop Support Medical recompete and procurement decisions. The top five customer agencies account for 91% of recent awards.

Simulab's primary vehicle position rests on multiple Indefinite Delivery Contracts (IDCs) with DLA: the flagship SPE2DH20D0029 contract carries 572 task orders generating $2.1 million in combined potential value, while the newer SPE2DH25D0010 supports 204 task orders worth $1.1 million. A 2025 General Services Administration Federal Supply Schedule contract (47QRAA25D009L) provides a $500,000 ceiling through May 2030 for off-the-shelf training devices and order-level material, supporting 198 task orders worth $5.2 million across civilian and defense agencies. The DLA Medical Capital Equipment Program accounts for 294 task orders, $2.7 million combined potential value. These vehicles generate the overwhelming majority of Simulab's federal revenues.

Simulab's capability portfolio centers on the TraumaMan family of trauma simulation systems and replaceable tissue packs (chest, neck, pericardiocentesis, surgical abdomen components), central line training simulators (CentralineMan Pro and variants), airway management trainers (AirwayMan and AirwayChild), ultrasound-guided procedural trainers (arterial line, thoracentesis, paracentesis), pediatric trauma simulators (TraumaChild), and consumable accessories (suturing pads, guidewires, simulated blood, IV bags, foam organs). Representative delivery orders include a $79.5 million TraumaMan V5 Purchase Program delivery order (June 2025, DLA), a $36.6 million Ultrasound Arterialine Package delivery order (May 2026, DLA), a $33.8 million rental and tissue set procurement from Uniformed Services University (January 2026, GSA Schedule), and a $28.7 million Ultrasound Paracentesis System PacerMan purchase order from the Department of Veterans Affairs Veterans Integrated Service Network 6 (September 2025, Total Small Business set-aside). Award magnitudes range from consumable tissue packs ($130–$1,100) to complete simulator systems ($16,100–$79,500) to enterprise-scale programs ($36 million IDCs).

Activity has been volatile: 138 awards in 2023, 87 in 2024, then recovered to 134 in 2025, with 77 recorded through mid-2026. Combined potential value stands at $84.8 million with $18.4 million obligated (22%). The company operates pure as a manufacturer-prime without named subcontractors; the one sub-award in the source record reflects Simulab receiving work as a sub to Arcticom LLC on an Air National Guard CBRNE consequence management task (2024), indicating minimal use of the sub channel.

NAICS concentration aligns tightly with inventory supply: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (779 awards), Surgical and Medical Instrument Manufacturing (302 awards), and Other Professional Equipment and Supplies Merchant Wholesalers (198 awards) dominate the footprint. PSC codes are similarly focused: Hospital Furniture, Equipment, Utensils, and Supplies (1,053 awards) and Medical and Surgical Instruments, Equipment, and Supplies (187 awards) account for 91% of awards.

Simulab competes on full-and-open without set-asides across nearly all awards, indicating a pure competitive posture grounded in product differentiation and DLA vendor relationships rather than small business reserve or strategic partnership leverage. The single exception—the VA VISN 6 award—used a Total Small Business set-aside, reflecting eligibility but not reliance. With 1,300+ federal awards and a decades-long DLA relationship, Simulab has established itself as the dominant single-source supplier of high-fidelity medical simulation equipment to federal defense and healthcare agencies, but that concentration creates singular recompete and customer dependency risk.